傑克股份(603337.SH):2022年度擬向合作銀行申請綜合授信不超45億元
格隆匯4月12日丨傑克股份(603337.SH)公佈,隨着公司經營規模的發展,為滿足公司及控股子公司生產需要,不斷提高公司的運行效率,降低資金成本,優化負債結構,提高風險抵抗能力以應對不斷變化的競爭需要,根據國家相關政策,並結合公司2022年的經營及投資計劃,公司擬在2022年度向合作銀行申請綜合授信不超過45億元,用於辦理中短期借款、商業匯票、票據貼現、貿易融資、開立信用證和保函等以滿足公司日常經營與戰略發展所需資金。
該議案尚需提交公司2021年年度股東大會審議,授信期限為自2021年年度股東大會審議通過之日起至2022年年度股東大會召開之日止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.